Fibromyalgia syndrome and spa therapy: myth or reality?

Giacomo M Guidelli, Sara Tenti, Emanuele De Nobili, Antonella Fioravanti, Giacomo M Guidelli, Sara Tenti, Emanuele De Nobili, Antonella Fioravanti

Abstract

Fibromyalgia syndrome (FS) is a common musculoskeletal disorder characterized by otherwise unexplained chronic widespread pain, a lowered pain threshold, high tender point counts, sleep disturbances, fatigue, headache, irritable bowel syndrome, morning stiffness, paraesthesias in the extremities, often psychological distress and depressed mood. Consequently, FS has a negative impact on working capacity, family life, social functioning and quality of life. Because of unknown etiology and not clearly understood pathogenesis, there is no standard therapy regime for FS. A variety of medical treatments, including antidepressants, opioids, analgesic or non-steroidal anti-inflammatory drugs, sedatives, muscle relaxants and antiepileptics, have been used to treat FS. Currently, no pharmacological treatment for FS is consistently successful. According to recent guidelines, the optimal treatment of FS requires a multidisciplinary approach with a combination of non-pharmacological and pharmacological treatment modalities. Spa therapy is a popular treatment for FS in many European countries, as well as in Japan and Israel. However, despite their long history and popularity spa treatments are still the subject of debate and their role in modern medicine is still not clear. The objective of this review is to summarize the currently available information on clinical effects and mechanism of action of spa therapy in FS. We also provide some suggestions for further development in this area.

Keywords: balneotherapy; fibromyalgia syndrome; mud-packs; randomized clinical trial; spa therapy.

References

    1. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol. 2005;75:6–21.
    1. McVeigh JG, McGaughey H, Hall M, Kane P. The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review. Rheumatol Int. 2008;29:119–30.
    1. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol. 1983;10:965–8.
    1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26–35.
    1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 1990;33:160–72.
    1. Spaeth M. Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res Ther. 2009;11:117.
    1. Neumann L, Buskila D. Quality of life and physical functioning of relatives of fibromyalgia patients. Semin Arthritis Rheum. 1997;26:834–9.
    1. Clauw DJ, Arnold LM, McCarberg BH, FibroCollaborative The science of fibromyalgia. Mayo Clin Proc. 2011;86:907–11.
    1. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011;7:518–27.
    1. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–95.
    1. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536–41.
    1. Klement A, Häuser W, Brückle W, et al. Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain. Schmerz. 2008;22:283–94.
    1. Busch A, Schachter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2003;3:CD003786.
    1. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings. J Rheumatol. 1992;19:98–103.
    1. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in the treatment of fibromyalgia? J Fam Pract. 1999;49:213–18.
    1. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain. 1999;3:235–44.
    1. Sarac AJ, Gur A. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des. 2006;12:47–57.
    1. Sukenik S, Flusser D, Abu-Shakra M. The role of SPA therapy in various rheumatic diseases. Rheum Dis Clin North Am. 1999;25:883–97.
    1. Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S. Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int. 2005;25:220–4.
    1. Fioravanti A, Cantarini L, Guidelli GM, Galeazzi M. Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol Int. 2011;31:1–8.
    1. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Knipschild PG. Balneotherapy for rheumatoid arthritis and osteoarthritis. Cochrane Database Syst Rev. 2000;2:CD000518.
    1. Yurtkuran M, Celiktas M. A randomized, controlled trial of balneotherapy in the treatment of patients with primary fibromyalgia syndrome. Phys Med Rehab Kuror. 1996;6:109–12.
    1. Buskila D, Abu-Shakra M, Neumman L, et al. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int. 2001;20:105–8.
    1. Neumman L, Sukenik S, Bolotin A, et al. The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol. 2001;20:15–9.
    1. Evcik D, Kizilay B, Gökçen E. The effects of balneotherapy on fibromyalgia patients. Rheumatol Int. 2002;22:56–9.
    1. Dönmez A, Karagülle MZ, Tercan N, et al. SPA therapy in fibromyalgia: a randomised controlled clinic study. Rheumatol Int. 2005;26:168–72.
    1. Ardiç F, Ozgen M, Aybek H, et al. Effects of balneotherapy on serum IL-1, PGE2 and LTB4 levels in fibromyalgia patients. Rheumatol Int. 2007;27:441–6.
    1. Fioravanti A, Perpignano G, Tirri G, et al. Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int. 2007;27:1157–61.
    1. Ozkurt S, Dönmez A, Zeki Karagülle M, Uzunoğlu E, Turan M, Erdoğan N. Balneotherapy in fibromyalgia: a single blind randomized controlled clinical study. Rheumatol Int. 2011 In press.
    1. Melzack R, Wall PD. Pain mechanism: a new theory. Science. 1965;150:971–9.
    1. Kuczera M, Kokot F. Effect of SPA therapy on the endocrine system. Stress reaction hormones. Pol Arch Med Wewn. 1996;95:11–20.
    1. Gur A, Cevik R, Sarac AJ, Colpan L, Em S. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 2004;63:1504–6.
    1. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER. Function on the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol. 1998;25:1374–81.
    1. Laatikainen T, Salminen K, Kohvakka A, Pettersson J. Response of plasma endorphins, prolactin and catecholamines in women to intense heat in a sauna. Eur J Appl Physiol Occup Physiol. 1988;57:98–102.
    1. Bellometti S, Galzigna L. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment. Int J Clin Pharm Res. 1999;19:27–33.
    1. Cozzi F, Lazzarin P, Todesco S, Cima L. Hypotalamic pituary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. Arthritis Rheum. 1995;38:724–6.
    1. Salemi S, Rethage J, Wollina U, et al. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol. 2003;30:146–50.
    1. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand. 2001;59:348–55.
    1. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Effect on prostaglandin E2 and leukotriene B4 levels by local administration of glucocorticoid in human masseter muscle myalgia. Acta Odontol Scand. 2002;60:29–36.
    1. Eckmekcioglu C, Strauss-Blasche G, Holzer F, Marktl W. Effect of sulfur baths on antioxidative defense systems, peroxide concentrations and lipid levels in patients with degenerative osteoarthritis. Forsch Komplementarmed Klass Naturheilkd. 2002;9:216–20.
    1. Bender T, Bariska J, Vághy R, Gomez R, Kovács Imre. Effect of balneotherapy on the antioxidant system—a controlled pilot study. Arch Med Res. 2007;38:86–9.
    1. Bagis S, Tamer L, Sahin G, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005;25:188–90.
    1. Langhorst J, Musial F, Klose P, Häuser W. Efficacy of hydrotherapy in fibromyalgia syndrome—a meta-analysis of randomized controlled clinical trials. Rheumatology. 2009;48:1155–9.
    1. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66:7–18.
    1. Buskila D. Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther. 2009;11:242.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever